Xiaoying Jia

State Key Laboratory Of Virology
Wuhan, 430062, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Boosting with Omicron-specific mRNA vaccine or historical SARS-CoV-2 vaccines elicits discriminating immune responses against Omicron variants.

Boosting with Omicron-specific mRNA vaccine or historical SARS-CoV-2 vaccines elicits discriminating immune responses against Omicron variants.

Journal: Acta pharmaceutica Sinica. B
Published: May 22, 2024

Integrative analysis of the metabolomes and transcriptomes of Ebola virus-infected cells: Uncovering pathways related to hepatic apoptosis.

Integrative analysis of the metabolomes and transcriptomes of Ebola virus-infected cells: Uncovering pathways related to hepatic apoptosis.

Journal: Genes & diseases
Published: March 07, 2024

An adenosine analog shows high antiviral potency against coronavirus and arenavirus mainly through an unusual base pairing mode.

An adenosine analog shows high antiviral potency against coronavirus and arenavirus mainly through an unusual base pairing mode.

Journal: Nature communications
Published: February 21, 2024

Identification of residues in Lassa virus glycoprotein 1 involved in receptor switch.

Identification of residues in Lassa virus glycoprotein 1 involved in receptor switch.

Journal: Virologica Sinica
Published: January 18, 2024

A bivalent Delta/BA.5 mRNA vaccine elicits broad immune responses against various lineages of SARS-CoV-2 including JN.1.

A bivalent Delta/BA.5 mRNA vaccine elicits broad immune responses against various lineages of SARS-CoV-2 including JN.1.

Journal: Virologica Sinica
Published: October 25, 2023

Long-term immune response to Omicron-specific mRNA vaccination in mice, hamsters, and nonhuman primates.

Long-term immune response to Omicron-specific mRNA vaccination in mice, hamsters, and nonhuman primates.

Journal: MedComm
Published: August 17, 2023

An engineered bispecific nanobody in tetrameric secretory IgA format confers broad neutralization against SARS-CoV-1&2 and most variants.

An engineered bispecific nanobody in tetrameric secretory IgA format confers broad neutralization against SARS-CoV-1&2 and most variants.

Journal: International journal of biological macromolecules
Published: July 28, 2023

Deletion of the first glycosylation site promotes Lassa virus glycoprotein-mediated membrane fusion.

Deletion of the first glycosylation site promotes Lassa virus glycoprotein-mediated membrane fusion.

Journal: Virologica Sinica
Published: January 11, 2023

Screening and Identification of Lassa Virus Entry Inhibitors from a Fragment-Based Drug Discovery Library.

Screening and Identification of Lassa Virus Entry Inhibitors from a Fragment-Based Drug Discovery Library.

Journal: Viruses
Published: October 24, 2022

Developing Next-Generation Protein-Based Vaccines Using High-Affinity Glycan Ligand-Decorated Glyconanoparticles.

Developing Next-Generation Protein-Based Vaccines Using High-Affinity Glycan Ligand-Decorated Glyconanoparticles.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 12, 2022

Bergamottin, a bioactive component of bergamot, inhibits SARS-CoV-2 infection in golden Syrian hamsters.

Bergamottin, a bioactive component of bergamot, inhibits SARS-CoV-2 infection in golden Syrian hamsters.

Journal: Antiviral research
Published: March 18, 2022

Screening of Botanical Drugs against SARS-CoV-2 Entry Reveals Novel Therapeutic Agents to Treat COVID-19.

Screening of Botanical Drugs against SARS-CoV-2 Entry Reveals Novel Therapeutic Agents to Treat COVID-19.

Journal: Viruses
Published: January 16, 2022
Showing 1-12 of 22

Last Updated: 09/26/2026